---
title: "Metabolic Bypass Mechanisms"
type: concept
tags:
  - mechanism
  - bypass
  - folate-pathway
  - sulfonamide
last_updated: "2026-09-04"
aliases:
  - Bypass Mechanisms
  - Metabolic Bypass
---

# Metabolic Bypass Mechanisms

**Metabolic Bypass** is a resistance mechanism whereby a bacterium circumvents an antibiotic-mediated enzymatic block either by overproducing an unaffected metabolic step, using an alternative metabolic pathway, or acquiring an exogenous, drug-resistant surrogate enzyme.

## Biochemical Principles
Many antibiotics are competitive antimetabolites:
- **Sulfonamides** mimic *para*-aminobenzoic acid (PABA) to inhibit dihydropteroate synthase (DHPS / FolP).
- **Trimethoprim** mimics dihydrofolate to inhibit dihydrofolate reductase (DHFR / FolA).

When these enzymes are blocked, bacterial synthesis of tetrahydrofolate (THF)—essential for thymidine, purine, and methionine biosynthesis—ceases, arresting bacterial growth.

### Target Bypass via Acquired Insensitive Enzymes
Rather than relying on mutations in native housekeeping genes (which often incur severe enzymatic velocity penalties), resistant bacteria acquire horizontally transferred genes:
- **`sul` Genes ([[sul1]], `sul2`, `sul3`)**: Encode structurally distinct DHPS enzymes that bind PABA and the pterin pyrophosphate donor with normal kinetics, but exhibit drastically diminished affinity for sulfonamides.
- **`dfr` Genes (`dfrA`, `dfrB`)**: Encode trimethoprim-resistant dihydrofolate reductases.

## Mobile Genetics
Because antimetabolite resistance genes like [[sul1]] are compact and highly beneficial under selective pressure, they are deeply entrenched in mobile genetic elements:
- [[sul1]] is a permanent structural component of the 3' conserved segment of Class 1 integrons.
- Often co-selected with beta-lactamases ([[blaTEM]]) and efflux pumps ([[tetA]]).

## Related Pages
- Entity: [[sul1]]
- Other Mechanisms: [[enzymatic-inactivation]], [[target-modification]], [[efflux-pumps]]
- Synthesis: [[amr-mechanisms-overview]]
